Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hepatocellular Cancer”

526 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 526 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Not applicableUnknownNCT03493763
What this trial is testing

Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 300
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03186898
What this trial is testing

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
NRG Oncology 115
Not applicableUnknownNCT06247293
What this trial is testing

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy

Who this might be right for
Hyperthermic Intraperitoneal ChemotherapyHepatocellular CarcinomaRuptured Liver
Zhujiang Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00820053
What this trial is testing

A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 450
Not applicableUnknownNCT02187081
What this trial is testing

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Who this might be right for
HCC
Southwest Hospital, China 380
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05987514
What this trial is testing

Multimodal Ultrasound and Hepatocellular Response to Local Treatments

Who this might be right for
Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07328828
What this trial is testing

Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence

Who this might be right for
RFS
Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Not applicableUnknownNCT05162898
What this trial is testing

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Who this might be right for
Recurrent Hepatocellular Cancer
Henan Cancer Hospital 90
Not applicableUnknownNCT04688606
What this trial is testing

Circulating Tumor Cell Capture for Early Diagnosis and Postoperative Tumor Recurrence Monitoring of Liver Cancer

Who this might be right for
Circulating Tumor Cell
Zhongnan Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00004248
What this trial is testing

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableNot Yet RecruitingNCT07350824
What this trial is testing

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

Who this might be right for
HCCMinimal Residual DiseaseRecurrence
Tongji Hospital 276
Not applicableActive Not RecruitingNCT05148572
What this trial is testing

Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 101
Next Page